RxDoctor Payments Data

Sajani Patel

Physician Assistant · Alpharetta, GANPI 1114624897

Payments from drug & device makers

$1,219in general payments, 2019–2025

Across 19 payments — averaging $64.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$624
  • Inspire Medical Systems, Inc.$221
  • Botanix SB Inc$154
  • AstraZeneca$133
  • AbbVie$50
  • Hikma Pharmaceuticals USA$23
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$1,219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,219 in reported general payments places this provider in the 70th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$30,216
Medicare patients
191
Services billed
654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide62$2,927
Epinephrine12$2,173
Azelastine Hcl37$936
Fluticasone Propionate55$700
Ofloxacin16$578
Famotidine76$553
Cefdinir22$401
Methylprednisolone55$265
Pantoprazole Sodium28$185
Doxycycline Monohydrate22$182
Doxycycline Hyclate15$178
Montelukast Sodium17$149
Mupirocin28$125
Mometasone Furoate16$124
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$79

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAEpinephrine$23$2,17312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Alpharetta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →